Zymeworks Inc.ZYMENASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank27
3Y CAGR-26.4%
5Y CAGR-47.6%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-26.4%/yr
vs -40.7%/yr prior
5Y CAGR
-47.6%/yr
Recent acceleration
Acceleration
+14.3pp
Accelerating
Percentile
P27
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 1.77% |
| 2024 | -6.27% |
| 2023 | -31.15% |
| 2022 | 4.43% |
| 2021 | 16.58% |
| 2020 | 44.91% |
| 2019 | 108.60% |
| 2018 | 35.77% |
| 2017 | 13.40% |
| 2016 | 49.33% |